https://www.fda.gov/news-events/press-announcements/fda-approves-interchangeable-biosimilar-multiple-inflammatory-diseases
0
0
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases - FDA.gov
+ 70 more
10/31/23 at 9:50pm
Organization
FDA.gov
Author
Office of the Commissioner
Details
24 words
Summarize
Pharmaceuticals & Biotech Business & Industrial Drugs & Medications FDA Inflammatory Diseases - FDA.gov Wezlana Stelara
The FDA approved Wezlana as an interchangeable biosimilar to Stelara for multiple inflammatory diseases.
Create an account or login to join the discussion